Bay Area's Arcus Biosciences Scores $107M, Initiates Two Clinical Trials Post author:Sam Post published:November 12, 2017 Post category:BioPharma Now totaling $227M, Arcus Biosciences announced it had closed a $107M Series C financing. Source: BioSpace You Might Also Like Following Recent Death, InVivo Therapeutics Temporarily Halts Enrollment in INSPIRE Study July 30, 2017 Merit Medical Coughs Up $100M for Bard, BD's Biopsy Assets November 15, 2017 <b>Mel-Mont Medical</b> Announces The Development Of M??a By XytoTest, A Self-Collected Cervical Sample That Seeks To Eradicate Cervical Cancer May 16, 2017
Following Recent Death, InVivo Therapeutics Temporarily Halts Enrollment in INSPIRE Study July 30, 2017
<b>Mel-Mont Medical</b> Announces The Development Of M??a By XytoTest, A Self-Collected Cervical Sample That Seeks To Eradicate Cervical Cancer May 16, 2017